(Q39447289)

English

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial (English)

1 reference

Europe PubMed Central

12 September 2017

phase III clinical trial

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

19

0 references

Geert Leroux-Roels

6

object named as

Geert Leroux-Roels

0 references

Peter Gottfried Kremsner

21

object named as

Peter Kremsner

1 reference

Europe PubMed Central

12 September 2017

5

object named as

Odile Launay

1 reference

Europe PubMed Central

12 September 2017

Janet E McElhaney

1

object named as

Janet E McElhaney

1 reference

Europe PubMed Central

12 September 2017

Shelly A McNeil

22

object named as

Shelly McNeil

1 reference

Europe PubMed Central

12 September 2017

16

object named as

Sharon E Frey

1 reference

Europe PubMed Central

12 September 2017

Lidia Oostvogels

26

object named as

Lidia Oostvogels

1 reference

Europe PubMed Central

12 September 2017

14

object named as

Ann R Falsey

1 reference

Europe PubMed Central

12 September 2017

Gerrit Adrianus van Essen

8

object named as

Gerrit A van Essen

1 reference

Europe PubMed Central

12 September 2017

4

object named as

Meral Esen

1 reference

Europe PubMed Central

12 September 2017

Florence Galtier

17

object named as

Florence Galtier

1 reference

Europe PubMed Central

12 September 2017

Shinn-Jang Hwang

18

object named as

Shinn-Jang Hwang

1 reference

Europe PubMed Central

12 September 2017

Jeanne-Marie Devaster

3

object named as

Jeanne-Marie Devaster

1 reference

Europe PubMed Central

12 September 2017

Christelle M Durand

11

object named as

Christelle Durand

1 reference

Europe PubMed Central

12 September 2017

Gregory J Feldman

15

object named as

Gregory Feldman

1 reference

Europe PubMed Central

12 September 2017

Jan Hendrik Richardus

24

object named as

Jan Hendrik Richardus

1 reference

Europe PubMed Central

12 September 2017

25

object named as

Andrew Trofa

1 reference

Europe PubMed Central

12 September 2017

Influence65 study group

27

object named as

Influence65 study group

1 reference

Europe PubMed Central

12 September 2017

author name string

Jiri Beran

2

1 reference

Europe PubMed Central

12 September 2017

Guillermo M Ruiz-Palacios

7

1 reference

Europe PubMed Central

12 September 2017

Adrian Caplanusi

9

1 reference

Europe PubMed Central

12 September 2017

Carine Claeys

10

1 reference

Europe PubMed Central

12 September 2017

Xavier Duval

12

1 reference

Europe PubMed Central

12 September 2017

Mohamed El Idrissi

13

1 reference

Europe PubMed Central

12 September 2017

Martina Kovac

20

1 reference

Europe PubMed Central

12 September 2017

Andrzej Nowakowski

23

1 reference

Europe PubMed Central

12 September 2017

publication date

19 March 2013

1 reference

Europe PubMed Central

12 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

12 September 2017

13

1 reference

Europe PubMed Central

12 September 2017

485-496

1 reference

Europe PubMed Central

12 September 2017

6

1 reference

Europe PubMed Central

12 September 2017

Influenza-associated hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of influenza vaccine in the community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines for preventing influenza in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines for preventing influenza in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines for preventing influenza in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The burden of community-acquired pneumonia in seniors: results of a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of lupus autoantibodies by adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymyalgia rheumatica prevalence in a population-based sample

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(13)70046-X

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39447289&oldid=1828595565"